These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2494376)

  • 1. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
    Schädlich HR; Büchler M; Beger HG
    Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
    Hesse B; Lankisch PG; Kunze H
    Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
    Freise J; Wittenberg H; Magerstedt P
    Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
    Freise J; Magerstedt P; Schmid K
    Enzyme; 1983; 30(3):209-12. PubMed ID: 6194983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
    Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T
    Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J; Schmidt FW; Magerstedt P; Schmid K
    Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca-ionophore A 23187 in the lung.
    Seeger W; Wolf H; Graubert E; Moser U; Neuhof H; Roka L
    Adv Exp Med Biol; 1983; 156():553-67. PubMed ID: 6190378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
    Kahle M; Klein U; König W; Martin U; Alles JU
    Z Gastroenterol; 1985 Dec; 23(12):687-93. PubMed ID: 3937346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
    Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
    Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis.
    Kahle M; König H; Filler RD
    Klin Wochenschr; 1989 Feb; 67(3):177-9. PubMed ID: 2494378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the anti-inflammatory serine esterase inhibitor, FOY, on phospholipase A2 (EC 3.1.1.4) activity in rabbit polymorphonuclear leukocytes.
    Kunze H; Bohn E; Damerau B
    Pharmacol Res Commun; 1983 Oct; 15(9):869-78. PubMed ID: 6417683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regeneration of full enzymatic activity by reoxidation of reduced pancreatic phospholipase A2.
    van Scharrenburg GJ; de Haas GH; Slotboom AJ
    Hoppe Seylers Z Physiol Chem; 1980 Apr; 361(4):571-6. PubMed ID: 7189740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice.
    Caronna R; Diana L; Nofroni I; Sibio S; Catinelli S; Sammartino P; Chirletti P
    Dig Dis Sci; 2005 May; 50(5):868-73. PubMed ID: 15906759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
    Davidson FF; Dennis EA; Powell M; Glenney JR
    J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
    Freise J
    Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2.
    de Haas GH; Dijkman R; van Oort MG; Verger R
    Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.
    Aarsman AJ; Mynbeek G; van den Bosch H; Rothhut B; Prieur B; Comera C; Jordan L; Russo-Marie F
    FEBS Lett; 1987 Jul; 219(1):176-80. PubMed ID: 2954856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of Woodward's Reagent K with pancreatic porcine phospholipase A2: modification of an essential carboxylase residue.
    Dinur D; Kantrowitz ER; Hajdu J
    Biochem Biophys Res Commun; 1981 May; 100(2):785-92. PubMed ID: 7271782
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
    van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
    FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural importance of the amino-terminal residue of pancreatic phospholipase A2.
    van Scharrenburg GJ; Jansen EH; Egmond MR; de Haas GH; Slotboom AJ
    Biochemistry; 1984 Dec; 23(25):6285-94. PubMed ID: 6441599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.